References
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., … Tischkowitz, M. (2014). Breast-cancer risk in families with mutations in PALB2. New England Journal of Medicine, 371, 497-506. doi:10.1056/NEJMoa1400382
Aoude, L. G., Xu, M., Zhao, Z. Z., Kovacs, M., Palmer, J. M., Johansson, P., … Hayward, N. K. (2014). Assessment of PALB2 as a candidate melanoma susceptibility gene. PLoS ONE, 9, e100683. doi:10.1371/journal.pone.0100683
Apostolou, P., & Fostira, F. (2013). Hereditary breast cancer: The era of new susceptibility genes. BioMed Research International, 2013, 747318. doi:10.1155/2013/747318
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J. W., Kamel, I.,… Bruno, M. (2013). International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut, 62, 339-347. doi:10.1136/gutjnl-2012-303108
Casadei, S., Norquist, B. M., Walsh, T., Stray, S., Mandell, J. B., Lee, M. K., … King, M. C. (2011). Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Research, 71, 2222-2229. doi:10.1158/0008-5472.CAN-10-3958
Ding, Y. C., Steele, L., Kuan, C. J., Greilac, S., & Neuhausen, S. L. (2011). Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Research and Treatment, 126, 771-778. doi:10.1007/s10549-010-1195-2
Hofstatter, E. W., Domchek, S. M., Miron, A., Garber, J., Wang, M., Componeschi, K., … Tung, N. (2011). PALB2 mutations in familial breast and pancreatic cancer. Familial Cancer Impact Factor, 10, 225-231. doi:10.1007/s10689-011-9426-1
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W.,… Klein, A. P. (2009). Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science, 324, 217. doi:10.1126/science.1171202
Park, J. Y., Zhang, F., & Andreassen, P. R. (2014). PALB2: The hub of a network of tumor suppressors involved in DNA damage responses. Biochimica et Biophysica Acta, 1846, 263-275. doi:10.1016/j.bbcan.2014.06.003
Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., … Stratton, M. R. (2007). PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature Genetics, 39, 165-167. doi:10.1038/ng1959
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., … Russell, C. A. (2007). American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: A Cancer Journal for Clinicians, 57, 75-89. doi:10.3322/canjclin.57.2.75
Verna, E. C., Hwang, C., Stevens, P. D., Rotterdam, H., Stavropoulos, S. N., Sy, C. D., … Frucht, H. (2010). Pancreatic cancer screening in a prospective cohort of high-risk patients: A comprehensive strategy of imaging and genetics. Clinical Cancer Research, 16, 5028-5037. doi:10.1158/1078-0432.CCR-09-3209
Zhang, Y. X., Wang, X. M., Kang, S., Li, X., & Geng, J. (2013). Common variants in the PALB2 gene confer susceptibility to breast cancer: A meta-analysis. Asian Pacific Journal of Cancer Prevention, 14, 7149-7154. doi:10.7314/APJCP.2013.14.12.7149